May 13, 2026 04:01PM
Mar 19, 2026 09:00AM
Mar 17, 2026 09:00AM
Mar 13, 2026 09:00AM
Mar 11, 2026 07:01PM
Mar 10, 2026 09:00AM
Mar 4, 2026 04:01PM Aquestive Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Jan 9, 2026 07:02AM
Jan 9, 2026 07:00AM
Nov 5, 2025 04:01PM
Oct 8, 2025 07:00AM
Oct 8, 2025 07:00AM
Sep 4, 2025 07:00AM
Sep 4, 2025 07:00AM Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm™
Aug 11, 2025 04:01PM
Jul 15, 2025 07:00AM
Jul 15, 2025 07:00AM
Jun 17, 2025 06:39AM
Jun 16, 2025 07:02AM
Jun 16, 2025 07:00AM
May 13, 2025 03:26PM Raymond James Reiterates Outperform Rating on Aquestive Therapeutics (AQST)
May 12, 2025 04:01PM
Apr 12, 2024 04:01PM
Mar 5, 2024 05:05PM
Nov 6, 2023 04:37PM
Nov 6, 2023 04:37PM
Oct 9, 2023 08:00AM
Oct 9, 2023 08:00AM Aquestive Therapeutics Provides Business Update
Sep 11, 2023 08:02AM
Sep 11, 2023 08:00AM
Sep 6, 2022 04:04PM
Aug 2, 2022 04:02PM
Aug 2, 2022 04:02PM
May 17, 2022 04:01PM
May 17, 2022 04:01PM Aquestive Therapeutics Announces CEO Transition
May 17, 2022 04:01PM
May 3, 2022 05:41PM
May 3, 2022 05:40PM
May 3, 2022 05:40PM
Mar 10, 2022 06:38AM
Mar 8, 2022 04:57PM
Mar 8, 2022 04:56PM Aquestive Therapeutics Reports Full Year 2021 Results Exceeding Revenue and EBITDA Guidance
Mar 8, 2022 04:56PM
Dec 21, 2021 05:15AM
Dec 20, 2021 10:49PM
Dec 20, 2021 10:49PM
Dec 13, 2021 08:00AM
Dec 13, 2021 08:00AM
Nov 2, 2021 04:30PM Aquestive Therapeutics Reports Third Quarter 2021 Financial Results, Provides Business Update and Improves Full Year Guidance
Nov 2, 2021 04:30PM

15,464 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All